We arrange outcome-linked financing to facilitate the use of cell and gene therapies by health plan members with a prior diagnosis. The use of outcome-linked financing helps payers maintain or expand access to potential cures, lower insurance costs, and hold cure developers accountable. It also helps developers bring their innovative products to the largest possible market.

  • To strengthen our financial solutions, we help payers with benefits management including contract design and management, creating tight provider networks, and tracking patient outcomes

  • We will work with payers and developers to create clear rules and procedures on clinical pathways and prior authorisation

  • We will coordinate between developers, payers, and neutral third parties to develop terms underlying outcomes-based financing contracts to maximise accountability and market access